Bain Capital Specialty Finance Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Bain Capital Specialty Finance stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BCSF, but not buy additional shares or sell existing shares.
View analyst ratings for Bain Capital Specialty Finance or view top-rated stocks.

Wall Street analysts have given Bain Capital Specialty Finance a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Bain Capital Specialty Finance wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Bain Capital Specialty Finance saw a increase in short interest in March. As of March 31st, there was short interest totaling 309,900 shares, an increase of 146.7% from the March 15th total of 125,600 shares. Based on an average daily trading volume, of 257,200 shares, the short-interest ratio is currently 1.2 days.
View Bain Capital Specialty Finance's Short Interest.

Bain Capital Specialty Finance is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Bain Capital Specialty Finance.

Bain Capital Specialty Finance will be holding an earnings conference call on Wednesday, May 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Bain Capital Specialty Finance, Inc. (NYSE:BCSF) posted its quarterly earnings results on Tuesday, February, 23rd. The company reported $0.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by $0.01. The business had revenue of $48.30 million for the quarter, compared to analyst estimates of $48.74 million. Bain Capital Specialty Finance had a negative net margin of 4.91% and a positive trailing twelve-month return on equity of 8.56%.
View Bain Capital Specialty Finance's earnings history.

Bain Capital Specialty Finance's stock was trading at $16.84 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BCSF shares have decreased by 6.8% and is now trading at $15.69.
View which stocks have been most impacted by COVID-19.

Bain Capital Specialty Finance announced a quarterly dividend on Wednesday, February 24th. Investors of record on Wednesday, March 31st will be given a dividend of $0.34 per share on Friday, April 30th. This represents a $1.36 dividend on an annualized basis and a yield of 8.67%. The ex-dividend date is Tuesday, March 30th.
View Bain Capital Specialty Finance's dividend history.

Bain Capital Specialty Finance pays an annual dividend of $1.36 per share and currently has a dividend yield of 8.68%. BCSF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Bain Capital Specialty Finance does not yet have a strock track record of dividend growth. The dividend payout ratio of Bain Capital Specialty Finance is 82.93%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Bain Capital Specialty Finance will have a dividend payout ratio of 100.00% in the coming year. This indicates that Bain Capital Specialty Finance may not be able to sustain their current dividend.
View Bain Capital Specialty Finance's dividend history.

4 brokerages have issued 12 month price targets for Bain Capital Specialty Finance's stock. Their forecasts range from $12.00 to $15.50. On average, they anticipate Bain Capital Specialty Finance's share price to reach $13.38 in the next twelve months. This suggests that the stock has a possible downside of 14.8%.
View analysts' price targets for Bain Capital Specialty Finance or view top-rated stocks among Wall Street analysts.

Some companies that are related to Bain Capital Specialty Finance include Fisker (FSR), Vivint Smart Home (VVNT), Foley Trasimene Acquisition Corp. II (BFT), BTRS (BTRS), Social Capital Hedosophia Holdings Corp. V (IPOE), Social Capital Hedosophia Holdings Corp. VI (IPOF), Paya (PAYA), Foley Trasimene Acquisition (WPF), Arko (ARKO), Porch Group (PRCH), Star Peak Energy Transition (STPK), Jaws Acquisition (JWS), Cohn Robbins (CRHC), Apollo Strategic Growth Capital (APSG) and Brooge Energy (BROG).
View all of BCSF's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), AbbVie (ABBV), The Walt Disney (DIS), Square (SQ), AT&T (T), Bristol-Myers Squibb (BMY), The Home Depot (HD), Advanced Micro Devices (AMD), Bank of America (BAC) and Energy Transfer (ET).

(BCSF) raised $156 million in an initial public offering (IPO) on Thursday, November 15th 2018. The company issued 7,500,000 shares at $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities served as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers.

Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF."

Bain Capital Specialty Finance's stock is owned by many different institutional and retail investors. Top institutional investors include Starr International Co. Inc. (1.20%), Mckinley Capital Management LLC Delaware (0.07%), CFO4Life Group LLC (0.07%) and FNY Investment Advisers LLC (0.01%). Company insiders that own Bain Capital Specialty Finance stock include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, Sally F Dornaus and Thomas A Hough.
View institutional ownership trends for Bain Capital Specialty Finance.

BCSF stock was sold by a variety of institutional investors in the last quarter, including Mckinley Capital Management LLC Delaware, and CFO4Life Group LLC.
View insider buying and selling activity for Bain Capital Specialty Finance or view top insider-selling stocks.

BCSF stock was bought by a variety of institutional investors in the last quarter, including Starr International Co. Inc., and FNY Investment Advisers LLC. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, Sally F Dornaus, and Thomas A Hough.
View insider buying and selling activity for Bain Capital Specialty Finance or or view top insider-buying stocks.

Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BCSF stock can currently be purchased for approximately $15.69.

Bain Capital Specialty Finance has a market capitalization of $1.01 billion and generates $197.95 million in revenue each year. The company earns $98.08 million in net income (profit) each year or $1.64 on an earnings per share basis.

The official website for Bain Capital Specialty Finance is www.baincapital.com.

Bain Capital Specialty Finance is headquartered at 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116.

Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected]